Status:
COMPLETED
Subject Preference for Scalp Psoriasis Treatment
Lead Sponsor:
Galderma R&D
Conditions:
Scalp Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The scalp is one of the most common affected sites in psoriatic patients as 79% of them have scalp involvement.It has also a psychological aspect with 31% of patients with scalp psoriasis indicating d...
Detailed Description
This study will be a multi-centre, investigator blinded, randomized, cross-over, intra-individual comparison in three parallel groups. In each parallel group, Clobetasol propionate shampoo, 0.05% wil...
Eligibility Criteria
Inclusion
- Male or female subjects, 18 years of age or older,
- Subjects with moderate to severe scalp psoriasis,
- Subjects who signed written informed consent prior to any study procedures.
Exclusion
- Subjects who need systemic treatment for their body psoriasis,
- Subjects who are at risk in terms of precautions, warnings and contra-indication,
- Female subjects who are pregnant, nursing or planning a pregnancy during the study,
- Subjects with a specific washout period for topical treatment(s) on the scalp,
- Subjects with a specific washout period for systemic treatment(s).
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT00438399
Start Date
February 1 2007
End Date
February 1 2008
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Dermatologica Azienda Ospedaliera Policlinico di Modena
Modena, Italy, 41100